Novavax Stock News

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / November 19, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you. Hoegh LNG Partners Lp (NYSE:HMLP) If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/hoegh-lng-partners-lp-loss-submission-form?prid=21398&wire=1Lead Plaintiff Deadline: December 27, 2021Class Period: August 22, 2019 - July 27, 2021 Allegations against HMLP include that: (1) the Partnership was facing issues with the PT ..

The European Unions drug regulator said it received an application from Novavax to authorize the American biotechnology companys coronavirus vaccine, a request that could significantly boost the continents vaccine supplies if its granted. In a statement yesterday [Macau time], the European Medicines Agency said it had begun evaluating data submitted by Novavax for its two-dose []

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Novavax, Inc. (Novavax) (NASDAQ: NVAX). The action charges Novavax with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects. As a result of Novavaxs

-- Novavax y Serum Institute of India reciben autorización de uso de emergencia para la vacuna COVID-19 en Filipinas GAITHERSBURG, Md. y PUNE, India, 18 de noviembre, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), una empresa de

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / November 18, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn''t require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below. Camber Energy, Inc. (NYSE:CEI) CONTACT JAKUBOWITZ ABOUT CEI:https://claimyourloss.com/securities/camber-energy-inc-loss-submission-form/?id=21372&from=1 Class Period: February 18, ..

Novavax, Inc. (NASDAQ:NVAX) shares gapped up prior to trading on Thursday . The stock had previously closed at $183.99, but opened at $194.08. Novavax shares last traded at $188.01, with a volume of 38,288 shares changing hands. A number of equities analysts recently commented on NVAX shares. Chardan Capital restated a neutral rating on shares []

The biotechnology company Novavax, Inc. (NVAX) has been in the headlines due to news related to its COVID-19 vaccine. The post Novavaxs COVID-19 Vaccine under EMAs Review for CMA; Shares Rise appeared first on Smarter Analyst .

Beset by delays, this vaccine is becoming available when low-income countries are desperately short of doses.

J.P. Morgan Stick to Their Hold Rating for Novavax

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Novavax, Inc. (Novavax or the Company) (NASDAQ: NVAX) securities between March 2, 2021 and October 19, 2021, inclusive (the Class Period). Novavax investors have until January 11, 2022 to file a lead plaintiff motion. If you suffered a loss on your Novavax inves

Lead Plaintiff Deadline Is January 11, 2022 Lead Plaintiff Deadline Is January 11, 2022

The European Medicines Agency (EMA) has begun evaluating an application for conditional marketing authorization for Novavax Inc''s (NASDAQ: NVAX ) COVID-19 vaccine. The protein-based vaccine candidate will be marketed in the European Union under the brand name Nuvaxovid. Separately, Novavax and Serum Institute of India Pvt. Ltd (SII) announced that the Philippine Full story available on Benzinga.com

LOS ANGELES--(BUSINESS WIRE)---- $NVAX #NVAX--SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc.

Today, shares of NVAX stock are taking off following a couple of key regulatory updates from the company from two core markets.

LOS ANGELES--(BUSINESS WIRE)---- $NVAX #investors--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Novavax, Inc. (NVAX) Investors